MG53 can alleviate hypertrophic cardiomyopathy, which is a primary myocardial disease characterized by pathological hypertrophy of the myocardium (Brieler et al., 2017; Teekakirikul et al., 2019). This evidence concerns the gene TRIM72 and myocardial disorder.